Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,860
archived clinical trials in
Acne

An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Site 4814
mi
from
Czestochowa,
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Site 4814
mi
from
Czestochowa,
Click here to add this to my saved trials
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dermatology and Laser Surgery
mi
from
Sacramento, CA
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dermatology and Laser Surgery
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
DermResearch, PLLC
mi
from
Louisville, KY
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
James Q. DelRosso DO, LLC
mi
from
Las Vegas, NV
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
James Q. DelRosso DO, LLC
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  10/14/2008
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 10/14/2008
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
Status: Enrolling
Updated:  3/5/2010
Department of Dermatology, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
Status: Enrolling
Updated: 3/5/2010
Department of Dermatology, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated:  2/18/2011
Palos Verdes Dermatology Associates
mi
from
Rolling Hills Estates, CA
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated: 2/18/2011
Palos Verdes Dermatology Associates
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated:  2/18/2011
Berlin Center
mi
from
Boynton Beach, FL
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated: 2/18/2011
Berlin Center
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
International Dermatology Research, Inc.
mi
from
Miami, FL
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Baumann Cosmetic & Research Institute
mi
from
Miami, FL
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Baumann Cosmetic & Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Palm Beach Esthetic Dermatology and Laser Center
mi
from
West Palm Beach, FL
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Palm Beach Esthetic Dermatology and Laser Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Gwinnett Clinical Research Center, Inc
mi
from
Snellville, GA
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Gwinnett Clinical Research Center, Inc
mi
from
Snellville, GA
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Dermatology Specialists Research
mi
from
Louisville, KY
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Dermatology Specialists Research
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
William Coleman III, MD, APMC
mi
from
Metairie, LA
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
William Coleman III, MD, APMC
mi
from
Metairie, LA
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Grekin Skin Institute
mi
from
Warren, MI
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Grekin Skin Institute
mi
from
Warren, MI
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
The Dermatology Group, P.C.
mi
from
Verona, NJ
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
The Dermatology Group, P.C.
mi
from
Verona, NJ
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Gramercy Park Dermatology
mi
from
New York, NY
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Gramercy Park Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Skin Search of Rochester, Inc
mi
from
Rochester, NY
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Skin Search of Rochester, Inc
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Dermatology Consulting Services
mi
from
High Point, NC
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Penn State Hershey Medical Center Department of Dermatology
mi
from
Hershey, PA
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Penn State Hershey Medical Center Department of Dermatology
mi
from
Hershey, PA
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
Yardley Dermatology Associates
mi
from
Yardley, PA
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
Yardley Dermatology Associates
mi
from
Yardley, PA
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
The Skin Wellness Center, PC
mi
from
Knoxville, TN
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
The Skin Wellness Center, PC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated:  1/23/2012
DermResearch, Inc.
mi
from
Austin, TX
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status: Enrolling
Updated: 1/23/2012
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
Status: Enrolling
Updated:  5/15/2012
Clinical Research Facility
mi
from
Dallas, TX
Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
Status: Enrolling
Updated: 5/15/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Aurora, CO
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Rochester, MN
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Henderson, NV
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Newark, NJ
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Ashville, NC
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Portland, OR
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne
Status: Enrolling
Updated:  9/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne
Status: Enrolling
Updated: 9/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
Status: Enrolling
Updated:  10/4/2012
Galderma Investigational site
mi
from
Baltimore, MD
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
Status: Enrolling
Updated: 10/4/2012
Galderma Investigational site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Parexel Early Phase
mi
from
Glendale, CA
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Parexel Early Phase
mi
from
Glendale, CA
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Odyssey Medispa
mi
from
Marina Del Rey, CA
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Odyssey Medispa
mi
from
Marina Del Rey, CA
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Rady Children's Hospital
mi
from
San Diego, CA
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Rady Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
FXM Research Corp Miami
mi
from
Miami, FL
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
FXM Research Corp Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
FMX Research Miramar
mi
from
Miramar, FL
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
FMX Research Miramar
mi
from
Miramar, FL
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Meda Phase, Inc
mi
from
Newnan, GA
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Meda Phase, Inc
mi
from
Newnan, GA
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Deaconess Clinic, Inc.
mi
from
Evansville, IN
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Deaconess Clinic, Inc.
mi
from
Evansville, IN
Click here to add this to my saved trials
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  12/17/2012
Dermatology Specialists
mi
from
Louisville, KY
Dose Range Study of CD5789 in Acne Vulgaris
A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 12/17/2012
Dermatology Specialists
mi
from
Louisville, KY
Click here to add this to my saved trials